Abstract

BackgroundA cluster-randomized trial recently demonstrated that an integrated behavioral and mobile technology intervention improved uptake of key components of a Prevention of Mother to Child Transmission (PMTCT) Option B+ program, among HIV- infected pregnant/breastfeeding women in India. To guide scale-up and optimize programmatic implementation, we conducted a mixed-methods evaluation of the feasibility and acceptability of this intervention.MethodsThe COMmunity Home Based INDia (COMBIND) study, was conducted in four districts of Maharashtra, India and randomized 119 integrated counseling and testing centers (ICTC) and their outreach workers (ORWs) to the COMBIND intervention, an integrated mHealth application that allowed digital data capture, PMTCT educational videos, SMS alerts for missed visits and reminder for visits, combined with personal empowerment and motivational interviewing training for ORWs. This qualitative evaluation was done through 15 in-depth interviews (IDIs) with ORWs and 15 IDIs with HIV-infected pregnant/breastfeeding women from the intervention arm. Utilizing a concurrent nested mixed-method evaluation approach, we assess the feasibility and acceptability of the study intervention.ResultsAll 30 participants reported that the PMTCT videos were essential in providing easy to understand information on critical aspects of HIV and necessary care related to PMTCT practices. A majority of the ORWs reported that the personal empowerment training with motivational interviewing skills training increased their confidence, motivation and gave them the tools for effectively supporting their clients. The mHealth application improved their working style as it facilitated targeted PMTCT information support, systemized data capture, streamlined their health education delivery practice and provided a sense of work satisfaction. The SMS appointment alerts improved retention in HIV care for mother and baby to the smaller proportion that had access to their phones. Despite reported improvements in knowledge and communication, few ORWs reported that structural challenges such as limited drug stocks, lack of HIV kits or unavailability of trained staff at ICTC, may hamper the uptake of PMTCT services, thus resulting in limited significant impacts of COMBIND on PMTCT outcomes.ConclusionThis study found that COMBIND intervention is scalable, feasible, beneficial and very well accepted by ORWs and patients, however structural challenges in goods and services remain.

Highlights

  • A cluster-randomized trial recently demonstrated that an integrated behavioral and mobile technology intervention improved uptake of key components of a Prevention of Mother to Child Transmission (PMTCT) Option B+ program, among HIV- infected pregnant/breastfeeding women in India

  • This study found that COMmunity Home Based INDia (COMBIND) intervention is scalable, feasible, beneficial and very well accepted by outreach workers (ORWs) and patients, structural challenges in goods and services remain

  • Using a concurrent, nested, mixedmethods design, this paper reports on the qualitative results of the impacts of an integrated mobile health and behavioral intervention that aimed to enhance the capacity of outreach workers (ORW) in the national program, to optimize PMTCT, Option B+ services uptake

Read more

Summary

Introduction

A cluster-randomized trial recently demonstrated that an integrated behavioral and mobile technology intervention improved uptake of key components of a Prevention of Mother to Child Transmission (PMTCT) Option B+ program, among HIV- infected pregnant/breastfeeding women in India. Current estimates indicate that mother to infant transmission of HIV can reduce from 25% to < 2% if HIV-infected pregnant women start anti-retroviral therapy (ART) early in their pregnancy and maintain exclusive breastfeeding [5, 6] These results helped inform the 2013 WHO revised guidelines that recommend the Option B+ approach and includes triple ART for all HIV infected pregnant and breastfeeding women, regardless of CD4+ cell count, intending to increase ART coverage and reducing vertical transmission [7]. This approach is designed to streamline the continuum of care related to the prevention of mother to child transmission (PMTCT), simplifying antiretroviral options to tripledrug therapy and avoiding the need for laboratory assessments to define ART eligibility or clinical disease staging. India initiated the Option B+ roll out on January 1, 2014, which includes the initiation of newborns on Nevirapine immediately after birth and promotion of exclusive breastfeeding

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call